Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Centelles – page 11

3 673 clinical trials in Centelles, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Centelles at a glance
3 673
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

3 673 trials in Centelles

Open in trial search

Efficacy and safety of gadopiclenol versus gadoteric acid‑enhanced MRA in adult patients with suspected vascular disease

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Gadopiclenol
  • Sponsor:Bracco Imaging S.p.A.

A study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Janssen Cilag International

Study of the safety and effects of gepotidacin in children aged 2 to 12 years with bacterial infections such as urinary tract infections

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Gepotidacin
  • Sponsor:Glaxosmithkline Research & Development Limited

IgA nephropathy

Recruiting

A study to evaluate the effect of zigakibart in adults with IgA nephropathy

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zigakibart
  • Sponsor:Novartis Pharma AG

Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Cardiac failure

Recruiting

Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:AstraZeneca AB

Study on Epcoritamab for Patients with Relapsed or Refractory Large B Cell Lymphoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Fundacion Geltamo

Study on How Nusinersen is Processed in Adults and Children with Spinal Muscular Atrophy Using the ThecaFlex DRx System

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nusinersen
  • Sponsor:Biogen Idec Research Limited

IgA nephropathy

Recruiting

Long-term safety and effectiveness study of atacicept in patients with IgA nephropathy (IgAN)

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atacicept
  • Sponsor:Vera Therapeutics Inc.

Cardiac failure

Recruiting

Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Patients Hospitalized with Heart Failure

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Colorado Prevention Center

Study on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belimumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Centelles

What the registry says about research in the country

01 Infectious Disease Prevention

Comprehensive research focusing on viral infections including studies evaluating vaccines against SARS-CoV-2, Herpes Zoster, and Cytomegalovirus. Multiple trials are examining vaccine efficacy and immune response in different age groups.

  • COVID-19 Vaccine Development
  • Viral Disease Prevention
  • Vaccine Safety Studies

Special attention is given to vaccine co-administration studies and booster dose evaluations in various populations.

02 Respiratory Health

Innovative clinical research examining treatments for respiratory conditions, including studies on RSV vaccines for older adults and asthma medication delivery systems. These trials aim to enhance treatment options for respiratory diseases.

  • RSV Prevention
  • Asthma Management
  • Pneumococcal Disease

Focus on developing effective preventive measures and treatments for respiratory infections.

03 Cardiovascular Health

Advanced research into cardiovascular disease prevention and treatment, with emphasis on managing hypercholesterolemia and reducing major adverse cardiovascular events. Studies evaluate new therapeutic approaches for heart health.

  • Cholesterol Management
  • Cardiovascular Risk Reduction
  • Preventive Cardiology

Trials focus on innovative medications and preventive strategies for cardiovascular health improvement.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.